Single-Use Bioreactors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, Other products), By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB), By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells), By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules), By Application (Research and Development, Bioproduction), By Usage (Lab scale production, Pilot scale production, large scale production), By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes), By Region & Competition, 2020-2030F

  • Industry : Healthcare
  • Pages : NA
  • Published Date : NA

Customization Enquiry 15 Years Strong – Enjoy 15% Off!

Buy Now
The report will be delivered in PDF format but without printing rights. It is recommended for individual clients for their personal use only.
Single User Licence $4500 $3825
The report will be delivered in printable PDF format along with the report’s data excel sheet for internal analysis. It is strongly recommended for a corporate team or an organization where users would like to access the report from multiple locations.!
Multi-User Licence $5500 $4675
The report will be delivered in printable PDF format along with the report’s data excel sheet. This license offers free 80 Analyst hours where the client can use TechSci’s research team. It is strongly recommended for an organization which wants to execute short ‘bespoke’ research project related to the scope of the purchased report.!
Custom Research Licence $8000 $6800
Main Content start here
Main Layout
Report Description

Report Description

Forecast Period

2026-2030

Market Size (2024)

USD 2.30 Billion

Market Size (2030)

USD 4.75 Billion

CAGR (2025-2030)

12.85%

Fastest Growing Segment

Gene Modified Cells

Largest Market

North America

Market Overview

Global Single-Use Bioreactors Market was valued at USD 2.30 billion in 2024 and is expected to reach USD 4.75 billion by 2030 with a CAGR of 12.85% during the forecast period. This can be ascribed to the increasing research and development (R&D) activities, collaborations, and strategic partnerships along with soaring demand for new vaccines, therapeutics, and rising chronic and infectious diseases. Also, growing development of monoclonal antibodies are anticipated to create demand for SUBs used for manufacturing facilities, thereby, expected to drive segment growth. In January 2022, HaemaLogiX Ltd (HaemaLogiX) and Lonza entered into an agreement for manufacturing the next clinical batch (cGMP) of HaemaLogiX’s lead multiple myeloma drug candidate and KappaMab, which is a monoclonal antibody and binds to a cell surface target which is called as kappa myeloma antigen (KMA) and found on myeloma cancer cells and not on normal plasma cells.

Key Market Drivers

Surge in Biopharmaceutical Demand and Biosimilar Production

The escalating demand for biopharmaceuticals, including monoclonal antibodies, vaccines, and biosimilars, is a primary catalyst propelling the SUBs market. Biopharmaceuticals offer targeted therapies with fewer side effects, making them preferred for treating chronic diseases such as cancer, diabetes, and autoimmune disorders. SUBs provide a cost-effective and flexible solution for biomanufacturing, reducing the need for extensive cleaning and sterilization processes inherent in traditional stainless-steel bioreactors.

Government initiatives worldwide are bolstering this growth. For instance, the U.S. National Institutes of Health (NIH) allocated approximately USD 47.6 billion in funding as of March 2024, emphasizing research in biologics and biosimilars. Similarly, the European Medicines Agency approved around 12 monoclonal antibodies in 2023, reflecting a supportive regulatory environment for biopharmaceuticals. The combination of rising biopharmaceutical demand and supportive government policies is expected to continue driving the adoption of SUBs, facilitating efficient and scalable production processes.

Cost Efficiency and Operational Flexibility

SUBs offer significant cost advantages over traditional bioreactors, primarily by eliminating the need for cleaning and sterilization between batches, thus reducing downtime and labor costs. Their modular design allows for easy scalability, accommodating varying production volumes without substantial infrastructure changes.

This cost-effectiveness is particularly beneficial for small and medium-sized enterprises (SMEs) and contract manufacturing organizations (CMOs), enabling them to enter the bioproduction market with lower capital investment. Governments are recognizing the potential of SUBs to enhance biomanufacturing capabilities. For example, initiatives like the U.S. Department of Health and Human Services' support for advanced manufacturing technologies underscore the strategic importance of flexible and cost-efficient bioproduction methods. The economic and operational benefits of SUBs are thus pivotal in their growing adoption across the biopharmaceutical industry.

Single-Use Bioreactors Market

Download Free Sample Report

Key Market Challenges

Concerns Over Leachables and Extractables

One of the primary challenges facing the SUBs market is the potential for leachables and extractables—chemical substances that can migrate from the single-use components into the bioproduct. These substances may affect product safety and efficacy, posing regulatory and quality assurance concerns.

Regulatory agencies like the FDA and the European Medicines Agency (EMA) have stringent guidelines for assessing and controlling leachable and extractables in biomanufacturing. Compliance with these regulations requires extensive testing and validation, which can be resource intensive. Moreover, the lack of standardized testing methods adds complexity to ensuring product safety.

Addressing these concerns is critical for the broader acceptance and reliability of SUBs in the production of sensitive biopharmaceuticals.

Scalability and Standardization Issues

While SUBs offer flexibility and cost advantages, scaling up production to meet large-volume demands presents challenges. SUBs are typically designed for small to medium-scale operations, and transitioning to larger scales may require significant modifications or hybrid systems, combining single-use and traditional stainless-steel components.

Additionally, the lack of standardization across different SUB systems can lead to compatibility issues, complicated process integration and technology transfer. This variability can hinder the efficiency of multi-site operations and limit the scalability of SUB-based manufacturing processes. Efforts are underway to develop standardized SUB platforms and interfaces, with support from industry consortia and regulatory bodies. However, achieving widespread standardization remains a work in progress, necessitating continued collaboration among stakeholders.

Key Market Trends

Integration of Digital Technologies in Bioprocessing

The incorporation of digital technologies such as the Internet of Things (IoT), artificial intelligence (AI), and machine learning into SUB operations is transforming bioprocessing. These technologies enable real-time monitoring, predictive maintenance, and enhanced process control, leading to improved product quality and reduced operational risks.

This digital transformation, often referred to as Bioprocessing 4.0, is gaining traction with support from governmental and regulatory bodies. For instance, the U.S. Food and Drug Administration (FDA) has been advocating for the adoption of advanced manufacturing technologies to ensure product quality and supply chain resilience. Such endorsements are encouraging the biopharmaceutical industry to invest in digital solutions, thereby accelerating the integration of these technologies into SUB systems.

The synergy between SUBs and digital technologies is expected to enhance efficiency, scalability, and compliance in biomanufacturing processes.

Expansion into Emerging Markets and Personalized Medicine

The SUBs market is witnessing significant growth in emerging economies, particularly in the Asia-Pacific region. Countries like China and India are investing heavily in biotechnology infrastructure, driven by government initiatives aimed at advancing healthcare and biomanufacturing capabilities. For example, China's "Made in China 2025" plan includes a focus on biotechnology, while India's "Biotech Vision 2030" outlines strategies to enhance the country's biotech sector.

Additionally, the rise of personalized medicine is influencing SUB adoption. SUBs are well-suited for producing small batches of customized therapies, aligning with the needs of personalized treatment approaches. Government support for personalized medicine research, such as the NIH's All of Us Research Program, is further propelling this trend.

The convergence of emerging market expansion and personalized medicine is thus shaping the future trajectory of the SUBs market.

Segmental Insights

Product Insights

Based on Product, the single use bioreactor systems segment captured the largest market share. Single-use bioreactor systems are widely used in biopharmaceutical manufacturing processes that require high product yield. The versatility, cost-effectiveness, and high mass production capability of single-use bioreactors would increase demand for the products leading to rapid market growth. Furthermore, the rising demand for quick development, and greater production of new bio-therapeutics including vaccines, antibodies, enzymes, and hormones, in addition to an increase in the product quantities that can be produced in these bioreactors, contributes to the market's ongoing expansion. In addition, an increase in the focus of key manufacturers on offering small-scale bioreactors will fuel segment growth over the next few years.

Single-Use Bioreactors Market

Download Free Sample Report

Regional Insights

Based on the region, North America held the largest share of the global Single-Use Bioreactors (SUBs) market. This dominance can be attributed to the region's advanced biopharmaceutical infrastructure, strong presence of key industry players, and robust investments in biotechnology research and development. The United States has been at the forefront of biologics manufacturing, driven by a mature regulatory environment, extensive government funding, and an active ecosystem of academic and commercial research institutions.

The National Institutes of Health (NIH) in the U.S. allocated over $45 billion in 2024 toward biomedical research, with a considerable portion directed toward biologics, gene therapies, and vaccine development. Such funding initiatives directly support the adoption of flexible and efficient biomanufacturing technologies like single-use bioreactors. Moreover, the region’s strong emphasis on personalized medicine and the growing number of clinical trials involving monoclonal antibodies, cell therapies, and recombinant proteins further increase demand for single-use systems.

Recent Developments

  • In June 2024, AGC Biologics announced the expansion of its manufacturing facility in Denmark by doubling its single-use bioreactor capacity to meet the rising industry demand.
  • In June 2024, WuXi Biologics, a CDMO, announced the installation of three sets of 5,000-liter single-use bioreactors in its second drug substance line at its Hangzhou drug substance manufacturing facility (MFG20), which began operations in 2021. The GMP production of these newly installed bioreactors is expected to increase the total capacity of the facility from 8,000 liters to 23,000 liters, further strengthening the company's ability to serve global clients.
  • In March 2024, Syngene International announced the expansion of its biologics CDMO capacity by building a manufacturing facility in India for clinical and commercial supply of drug substances.

Key Market Players

  • ABEC, INC.
  • Able Corporation & Biott Corporation.
  • BBI-Biotech Gmbh.
  • Cellexus Biosystems PLC.
  • Celltainer Biotech BV.
  • Danaher Corporation
  • Distek Inc.
  • Eppendorf AG.
  • G&G Technologies, Inc.
  • Getinge AB

By Product

By Type

By Type of Cell

By Molecule

By Application

By Usage

By End User

By Region
  • Single use bioreactor systems
  • Single use media bags
  • Single use filtration assemblies
  • Other products
  • Stirred tank SUB
  • Wave induced SUB
  • Bubble Column SUB
  • Other SUB
  • Mammalian Cell
  • Bacterial Cell
  • Yeast Cell
  • Other Cells
  • Monoclonal Antibodies
  • Vaccines
  • Gene Modified Cells
  • Stem Cells
  • Other molecules
  • Research and Development
  • Bioproduction
  • Lab scale production
  • Pilot scale production
  • Large scale production
  • Pharmaceutical and Biopharmaceutical companies
  • CROSs & CMOS
  • Academic and Research Institutes
  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East & Africa

Report Scope:

In this report, the Global Single-Use Bioreactors Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

  • Single-Use Bioreactors Market, By Product:

o   Single use bioreactor systems

o   Single use media bags

o   Single use filtration assemblies

o   Other products

  • Single-Use Bioreactors Market, By Type:

o   Stirred tank SUB

o   Wave induced SUB

o   Bubble Column SUB

o   Other SUB

  • Single-Use Bioreactors Market, By Type of Cell:

o   Mammalian Cell

o   Bacterial Cell

o   Yeast Cell

o   Other Cells

  • Single-Use Bioreactors Market, By Molecule:

o   Monoclonal Antibodies

o   Vaccines

o   Gene Modified Cells

o   Stem Cells

o   Other molecules

  • Single-Use Bioreactors Market, By Application:

o   Research and Development

o   Bioproduction

  • Single-Use Bioreactors Market, By Usage:

o   Lab scale production

o   Pilot scale production

o   Large scale production

  • Single-Use Bioreactors Market, By End User:

o   Pharmaceutical and Biopharmaceutical companies

o   CROSs & CMOS

o   Academic and Research Institutes

  • Single-Use Bioreactors Market, By Region:

o   North America

§  United States

§  Mexico

§  Canada

o   Europe

§  France

§  Germany

§  United Kingdom

§  Italy

§  Spain

o   Asia-Pacific

§  China

§  India

§  South Korea

§  Japan

§  Australia

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East and Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Single-Use Bioreactors Market.

Available Customizations:

Global Single-Use Bioreactors Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Global Single-Use Bioreactors Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com

Table of content

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.     Markets Covered

1.2.2.     Years Considered for Study

1.2.3.     Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Voice of Customer

5.    Global Single-Use Bioreactors Market Outlook

5.1.  Market Size & Forecast

5.1.1.     By Value

5.2.  Market Share & Forecast

5.2.1.     By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, other products)

5.2.2.     By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB)

5.2.3.     By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells)

5.2.4.     By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules)

5.2.5.     By Application (Research and Development, Bioproduction)

5.2.6.     By Usage (Lab scale production, Pilot scale production, large scale production)

5.2.7.     By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes)

5.2.8.     By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)

5.2.9.     By Company (2024)

5.3.  Market Map

5.3.1 By Product

5.3.2 By Type

5.3.3 By Type of Cell

5.3.4 By Molecule

5.3.5 By Application

5.3.6 By Usage

5.3.7 By End User

5.3.5 By Region

6.    North America Single-Use Bioreactors Market Outlook

6.1.  Market Size & Forecast          

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, other products)

6.2.2.     By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB)

6.2.3.     By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells)

6.2.4.     By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules)

6.2.5.     By Application (Research and Development, Bioproduction)

6.2.6.     By Usage (Lab scale production, Pilot scale production, large scale production)

6.2.7.     By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes)

6.2.8.     By Country

6.3.  North America: Country Analysis

6.3.1.     United States Single-Use Bioreactors Market Outlook

6.3.1.1.         Market Size & Forecast

6.3.1.1.1.             By Value

6.3.1.2.         Market Share & Forecast

6.3.1.2.1.             By Product

6.3.1.2.2.             By Type

6.3.1.2.3.             By Type of Cell

6.3.1.2.4.             By Molecule

6.3.1.2.5.             By Application

6.3.1.2.6.             By Usage

6.3.1.2.7.             By End User

6.3.2.     Canada Single-Use Bioreactors Market Outlook

6.3.2.1.         Market Size & Forecast

6.3.2.1.1.             By Value

6.3.2.2.         Market Share & Forecast

6.3.2.2.1.             By Product

6.3.2.2.2.             By Type

6.3.2.2.3.             By Type of Cell

6.3.2.2.4.             By Molecule

6.3.2.2.5.             By Application

6.3.2.2.6.             By Usage

6.3.2.2.7.             By End User

6.3.3.     Mexico Single-Use Bioreactors Market Outlook

6.3.3.1.         Market Size & Forecast

6.3.3.1.1.             By Value

6.3.3.2.         Market Share & Forecast

6.3.3.2.1.             By Product

6.3.3.2.2.             By Type

6.3.3.2.3.             By Type of Cell

6.3.3.2.4.             By Molecule

6.3.3.2.5.             By Application

6.3.3.2.6.             By Usage

6.3.3.2.7.             By End User

7.    Europe Single-Use Bioreactors Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, other products)

7.2.2.     By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB)

7.2.3.     By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells)

7.2.4.     By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules)

7.2.5.     By Application (Research and Development, Bioproduction)

7.2.6.     By Usage (Lab scale production, Pilot scale production, large scale production)

7.2.7.     By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes)

7.2.8.     By Country

7.3.  Europe: Country Analysis

7.3.1.     France Single-Use Bioreactors Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Product

7.3.1.2.2.             By Type

7.3.1.2.3.             By Type of Cell

7.3.1.2.4.             By Molecule

7.3.1.2.5.             By Application

7.3.1.2.6.             By Usage

7.3.1.2.7.             By End User

7.3.2.     Germany Single-Use Bioreactors Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Product

7.3.2.2.2.             By Type

7.3.2.2.3.             By Type of Cell

7.3.2.2.4.             By Molecule

7.3.2.2.5.             By Application

7.3.2.2.6.             By Usage

7.3.2.2.7.             By End User

7.3.3.     United Kingdom Single-Use Bioreactors Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Product

7.3.3.2.2.             By Type

7.3.3.2.3.             By Type of Cell

7.3.3.2.4.             By Molecule

7.3.3.2.5.             By Application

7.3.3.2.6.             By Usage

7.3.3.2.7.             By End User

7.3.4.     Italy Single-Use Bioreactors Market Outlook

7.3.4.1.         Market Size & Forecast

7.3.4.1.1.             By Value

7.3.4.2.         Market Share & Forecast

7.3.4.2.1.             By Product

7.3.4.2.2.             By Type

7.3.4.2.3.             By Type of Cell

7.3.4.2.4.             By Molecule

7.3.4.2.5.             By Application

7.3.4.2.6.             By Usage

7.3.4.2.7.             By End User

7.3.5.     Spain Single-Use Bioreactors Market Outlook

7.3.5.1.         Market Size & Forecast

7.3.5.1.1.             By Value

7.3.5.2.         Market Share & Forecast

7.3.5.2.1.             By Product

7.3.5.2.2.             By Type

7.3.5.2.3.             By Type of Cell

7.3.5.2.4.             By Molecule

7.3.5.2.5.             By Application

7.3.5.2.6.             By Usage

7.3.5.2.7.             By End User

8.    Asia-Pacific Single-Use Bioreactors Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, other products)

8.2.2.     By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB)

8.2.3.     By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells)

8.2.4.     By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules)

8.2.5.     By Application (Research and Development, Bioproduction)

8.2.6.     By Usage (Lab scale production, Pilot scale production, large scale production)

8.2.7.     By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes)

8.2.8.     By Country

8.3.  Asia-Pacific: Country Analysis

8.3.1.     China Single-Use Bioreactors Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Product

8.3.1.2.2.             By Type

8.3.1.2.3.             By Type of Cell

8.3.1.2.4.             By Molecule

8.3.1.2.5.             By Application

8.3.1.2.6.             By Usage

8.3.1.2.7.             By End User

8.3.2.     India Single-Use Bioreactors Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Product

8.3.2.2.2.             By Type

8.3.2.2.3.             By Type of Cell

8.3.2.2.4.             By Molecule

8.3.2.2.5.             By Application

8.3.2.2.6.             By Usage

8.3.2.2.7.             By End User

8.3.3.     Japan Single-Use Bioreactors Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Product

8.3.3.2.2.             By Type

8.3.3.2.3.             By Type of Cell

8.3.3.2.4.             By Molecule

8.3.3.2.5.             By Application

8.3.3.2.6.             By Usage

8.3.3.2.7.             By End User

8.3.4.     South Korea Single-Use Bioreactors Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Product

8.3.4.2.2.             By Type

8.3.4.2.3.             By Type of Cell

8.3.4.2.4.             By Molecule

8.3.4.2.5.             By Application

8.3.4.2.6.             By Usage

8.3.4.2.7.             By End User

8.3.5.     Australia Single-Use Bioreactors Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Product

8.3.5.2.2.             By Type

8.3.5.2.3.             By Type of Cell

8.3.5.2.4.             By Molecule

8.3.5.2.5.             By Application

8.3.5.2.6.             By Usage

8.3.5.2.7.             By End User

9.    South America Single-Use Bioreactors Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, other products)

9.2.2.     By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB)

9.2.3.     By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells)

9.2.4.     By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules)

9.2.5.     By Application (Research and Development, Bioproduction)

9.2.6.     By Usage (Lab scale production, Pilot scale production, large scale production)

9.2.7.     By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes)

9.2.8.     By Country

9.3.  South America: Country Analysis

9.3.1.     Brazil Single-Use Bioreactors Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Product

9.3.1.2.2.             By Type

9.3.1.2.3.             By Type of Cell

9.3.1.2.4.             By Molecule

9.3.1.2.5.             By Application

9.3.1.2.6.             By Usage

9.3.1.2.7.             By End User

9.3.2.     Argentina Single-Use Bioreactors Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Product

9.3.2.2.2.             By Type

9.3.2.2.3.             By Type of Cell

9.3.2.2.4.             By Molecule

9.3.2.2.5.             By Application

9.3.2.2.6.             By Usage

9.3.2.2.7.             By End User

9.3.3.     Colombia Single-Use Bioreactors Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Product

9.3.3.2.2.             By Type

9.3.3.2.3.             By Type of Cell

9.3.3.2.4.             By Molecule

9.3.3.2.5.             By Application

9.3.3.2.6.             By Usage

9.3.3.2.7.             By End User

10.  Middle East and Africa Single-Use Bioreactors Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, other products)

10.2.2.  By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB)

10.2.3.  By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells)

10.2.4.  By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules)

10.2.5.  By Application (Research and Development, Bioproduction)

10.2.6.  By Usage (Lab scale production, Pilot scale production, large scale production)

10.2.7.  By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes)

10.2.8.  By Country

10.3.              MEA: Country Analysis

10.3.1.  South Africa Single-Use Bioreactors Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Product

10.3.1.2.2.           By Type

10.3.1.2.3.           By Type of Cell

10.3.1.2.4.           By Molecule

10.3.1.2.5.           By Application

10.3.1.2.6.           By Usage

10.3.1.2.7.           By End User

10.3.2.  Saudi Arabia Single-Use Bioreactors Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Product

10.3.2.2.2.           By Type

10.3.2.2.3.           By Type of Cell

10.3.2.2.4.           By Molecule

10.3.2.2.5.           By Application

10.3.2.2.6.           By Usage

10.3.2.2.7.           By End User

10.3.3.  UAE Single-Use Bioreactors Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Product

10.3.3.2.2.           By Type

10.3.3.2.3.           By Type of Cell

10.3.3.2.4.           By Molecule

10.3.3.2.5.           By Application

10.3.3.2.6.           By Usage

10.3.3.2.7.           By End User

11.  Market Dynamics

11.1.              Drivers

11.1.1 Growing demand for lab automation activities

11.1.2 Growing adoption of lab informatics by biobanks

11.1.3 Growing introduction of technologically advanced software services

11.2.              Challenges

11.2.1 Lack of integration standards for laboratory informatics

11.2.2 Stringent Regulations

12.  Market Trends & Developments

12.1.              Recent Development

12.2.              Mergers & Acquisitions

12.3.              Product Launches

13.  Global Single-Use Bioreactors Market: SWOT Analysis

14.  Porter’s Five Forces Analysis

14.1.              Competition in the Industry

14.2.              Potential of New Entrants

14.3.              Power of Suppliers

14.4.              Power of Customers

14.5.              Threat of Substitute Products

15.  Competitive Landscape

15.1.              ABEC, INC.

15.1.1.     Business Overview

15.1.2.     Company Snapshot

15.1.3.     Products & Services

15.1.4.     Financials (As Reported)

15.1.5.     Recent Developments

15.1.6.     Key Personnel Details

15.1.7.     SWOT Analysis

15.2.           Able Corporation & Biott Corporation.

15.3.           BBI-Biotech Gmbh.

15.4.           Cellexus Biosystems PLC.

15.5.           Celltainer Biotech BV.

15.6.           Danaher Corporation

15.7.           Distek Inc.

15.8.           Eppendorf AG.

15.9.           G&G Technologies, Inc.

15.10.         Getinge AB

16. Strategic Recommendations

17. About Us & Disclaimer

Figures and Tables

Frequently asked questions

Frequently asked questions

The market size of the Global Single-Use Bioreactors Market was estimated to be USD 2.30 billion in 2024.

ABEC, INC., Able Corporation & Biott Corporation., BBI-Biotech Gmbh., Cellexus Biosystems PLC., Celltainer Biotech BV. were some of the key players operating in the Global Single-Use Bioreactors Market.

Concerns Over Leachables and Extractables and Scalability and Standardization Issues are some of the major challenges faced by the Global Single-Use Bioreactors Market in the upcoming years.

Surge in Biopharmaceutical Demand and Biosimilar Production and Cost Efficiency and Operational Flexibility are the major drivers for the Global Single-Use Bioreactors Market.

Related Reports
Related Reports

We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site or by closing this box, you consent to our use of cookies. More info.